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ABSTRACT
Background: High cholesterol level is a risk factor for 
cardiovascular disease.  The objective of the study was to 
estimate the prevalence and correlates for high 
cholesterol levels in Lusaka district, Zambia.  
Methods: A modified World Health Organization 
STEPwise approach to surveillance method was used to 
collect data among adults. Odds ratios and their 95% 
confidence intervals were used to estimate magnitudes of 
associations.
Results: A total of 1928 individuals participated in the 
survey.  Overall, 15.8% (12.8% among male and 17.3% 
among female, p=0.013) respondents had high 
cholesterol levels. Compared to males aged 45 years or 
older, males of age 25-34 years were 44% less likely to 
have raised cholesterol levels.  Males with body mass 
index (BMI) <18.5 and 25.0-29.9 were 87% less and 2.49 
times more likely to have raised cholesterol, respectively, 
compared to males with BMI of 30 or more.  Meanwhile, 
females aged 25-34 years were 22% less likely to have 
raised cholesterol compared to females aged 45 years or 
older.  Compared to females with BMI of 30 or more, 
females with BMI of 18.5-24.9 and 25.0-29.9 were 33% 
less and 57% more likely, respectively, to have raised 
cholesterol levels.  
Conclusion: A series of surveys to determine changes in 
total and LDL cholesterol are needed to estimate changes 
in the health level of the residents in Lusaka.  These 
results could be used in the formulation of an action plan 
to prevent and control high cholesterol and its 
consequences among Zambian urban residents.  
INTRODUCTION
It is estimated that by 2020 cardiovascular diseases 
(CVD) will become the leading cause of the global 
disease burden, accounting for 73 percent of total global 
1,2mortality and 56 percent of total morbidity . Total 
cholesterol level is a risk factor for cardiovascular 
3disease .  A 2007 study reported from the Women's 
Health Study that high levels of total cholesterol is 
significantly associated with an increased risk for 
ischemic stroke, even in women who are otherwise 
4 5healthy .  Capewell and Ford  also reported that total 
cholesterol has major public health importance as a cause 
of coronary heart disease and ischemic stroke.  In a meta-
analysis using data from 18 cohort studies involving a 
total of 257,384 black men and women and white men 
and women whose risk factors for cardiovascular disease 
were measured at the ages of 45, 55, 65, and 75 years, 
6Berry et al  reported that differences in risk-factor burden 
(e.g. cholesterol) translated into marked differences in 
the lifetime risk of cardiovascular disease. These 
differences were consistent across race and birth cohorts.
Generally, the CVD epidemic was estimated to be on the 
7decline in developed countries  but it is emerging in 
1developing countries with little public health response .  
A similar trend in total cholesterol has also been 
8observed .  The prevalence of hypercholesterolaemia in 
Dar-es-Salaam, Tanzania increased by 3-folds and 10-
folds among males and females, respectively, in rural 
areas; and by 2-folds and 7-folds among males and 
females, respectively, in urban areas between 1987 and 
91998 .
Overweight and obesity is one of the risk factors for high 
cholesterol.  Although adiposity is associated with 
hypercholesterolemia, controversy surrounds which 
adiposity measures to use in their associations with 
10cardiovascular disease risk factors.  Schroder et al.  
reports that body mass index (BMI) is an easily and 
reliably obtained measure of relative body size, and 
11Ferrannini  reported that BMI is often used as an indirect 
index of adiposity and has been strongly associated with 
cardiovascular disease risk.  In a meta-analysis, van Dijk 
12et al.  concluded that waist circumference should be used 
in clinical and research studies compared with body mass 
index, although in men the correlations between WC and 
HDL, and between BMI and HDL were similar; and 
moderate correlations were observed for WC and BMI 
with HDL.  Therefore, BMI can be used in determining 
the association between overweight/obesity and high 
cholesterol levels.  A significant positive association has 
13,14been reported between BMI and cholesterol .  Contrary 
15to the above finding, Ernst et al.  observed a negative 
association between BMI and HDL-cholesterol.  
16Meanwhile, Walton et al.  did not find a significant 
association between BMI and HDL-cholesterol 
concentrations.  The differences in the above findings 
indicate differences in the study populations in the terms 
of adipose tissue-free mass, skeletal muscle and body cell 
17mass .
Whilst the prevalence of total cholesterol and its 
correlates is well documented in developed countries, 
there is little information on its magnitude and associated 
1factors in Africa.  Reddy and Yusuf  reported that 
developing countries are at different levels of 
socioeconomic growth, demographic change, and 
lifestyle practices; and hence the direction and pace of the 
CVD epidemic is unlikely to be uniform.  It is thus 
important to track the CVD epidemic in each country, and 
hence the current study.  The current study was designed 
to estimate the prevalence and correlates for high total 
cholesterol in Lusaka, the capital city of Zambia. 
METHODS
Study setting and design: The survey from which this 
report was derived was conducted in Lusaka, capital city 
of Zambia with an estimated population of 2,198,996 
(CSO 2011 Census of Population and Housing).  The data 
from which this study is generated was a community-
based cross sectional survey.
Sample size and sampling: The StatCalc programme in 
Epi Info version 6.04 was used to compute the sample 
size. The following parameters were used in the 
computation of the sample size: level of confidence 
measure of 1.96, margin of error of 5%, baseline level of 
the indicator of 50% (as no estimates existed), 8 
provincial estimates, and a design effect of 2. Using the 
above parameters, a sample size of 6128 was computed 
and after adjusting for 80% response rate, the required 
sample size was 7660. This sample size was 
proportionally distributed to the 8 provinces according to 
their provincial populations, and the sample size for 
Lusaka district was 1915.
Lusaka district in Lusaka province was conveniently 
selected because it was the most urbanized district in 
Zambia. The other districts in Lusaka province were 
Kafue a peri-urban district; and Chongwe a rural district. 
Five out of 7 constituencies in Lusaka district were 
randomly selected. From each selected constituency, one 
ward was randomly selected. The number of Standard 
Enumeration Areas (SEAs) selected in each ward was 
proportional to its population size. SEAs were selected 
using a systematic random sampling method. 
Households were then systematically sampled in order to 
widely cover the selected SEAs. All persons of ages 25 or 
more years were invited to participate in the survey.
Data collection: The modified World Health 
Organization (WHO) STEPS approach was conducted. 
The WHO STEPwise approach to Surveillance (STEPS) 
is a simple, standardized method for collecting, analysing 
and disseminating data in WHO member countries. This 
approach combines the collection of self-reported socio-
demographic characteristics as well as trained 
interviewer assessment of weight and height as well as 
relevant laboratory measurements. Data collection was 
done in 2007. 
Ethical considerations: The study protocol was 
approved by the University of Zambia Research Ethics 
Committee.  Permission to conduct the study was given 
by the Ministry of Health, Zambia. Informed consent was 
obtained from each study participant.  Interviews were 
conducted in the homes of the participants, and waist 
measurement was taken in a private area.
Variables
Weight and height measurements: Weight, recorded in 
kilograms, was measured using the Heine 737 portable 
professional adult scale (Seca GmbH & Co. kg Humburg, 
German), and the Seca Brand 214 Portable Stadiometer 
was used to measure height that was recorded in 
centimeters (Seca GmbH & Co. kg Humburg, German).
Waist and hip circumferences: The waist circumference, 
recorded in centimeters, was measured using the Figure 
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® Finder Tape Measure. The tape measure was wrapped 
around the waist between the inferior margin of the last 
rib and the crest of the ilium directly over the skin or light 
clothing. Using the same tape measure, the hip 
circumference was measured at the maximum 
circumference over the buttocks and recorded in 
centimeters.
Total cholesterol estimation: Fasting blood was collected 
for the estimation of cholesterol levels. The Accutrend 
GCT (Glucose, Cholesterol and Triglycerides) Meter 
Three-in-One system (Roche Diagnostics GmbH, 
Mannheim, German) was use to estimate total cholesterol 
18levels that were recorded in mmol/L.  Gottschling et al.  
compared cholesterol results obtained using the 
Accutrend system with capillary blood with results 
ob ta ined  us ing  the  cho les te ro l  ox idase /p -
aminophenazone (CHOD-PAP) method with the 
respective capillary sera.  They found that the Accutrend 
cholesterol was a reliable system for the determination of 
total cholesterol.
Data entry and analysis: Data were entered using Epi 
Data version 3.1 by two trained data entry clerks.  The 
data entry template had consistency and range checks 
embedded in it.  After the data were validated and 
cleaned, they were exported to SPSS version 14.0 for 
analysis.
The analysis included running cross tabulations and 
logistic regression for each sex.  The unadjusted odds 
ratio and its 95% confidence interval were used to 
estimate the magnitude of association in bivariate 
analysis.  We calculated the proportion of high total 
cholesterol and also by stratifying by sex (gender). 
Meanwhile, in multivariate analysis the adjusted odds 
ratio and its 95% confidence interval were used to 
estimate the magnitude of association.  A backward 
variable selection method was used to enter variables in a 
multivariate logistic model.  Body mass Index (BMI) was 
2 2categorized as <18.5 kg/m  (lean), 18.5-24.9 kg/m  
2 2(normal), 25.0-29.9 kg/m  (overweight), and 30+ kg/m  
(obese). A waist-hip ratio was grouped into two: <1 
(normal) and >1 (raised); and cholesterol levels were 
either normal (<5.2 mmol/L) or otherwise raised.
RESULTS
A total of 1928 individuals participated in the survey, of 
which 33.0% were males.  About half of the participants 
were of age 25-34 years (53.2%) as shown in Table 1.  
Overall, 15.8% (12.8% of males and 17.3% of females, 
p=0.013) of the respondents had raised cholesterol levels 
(Table 2).
Table 1: Demographic characteristics for the sampled 
population in Lusaka, Zambia
Table 2:  Distribution of  cholesterol levels by sex in Lusaka, 
Zambia
Factors associated with raised cholesterol levels are 
shown in Table 3.  Age, body mass index, and waist hip 
ratio were significantly associated with raised levels of 
cholesterol among males.  Compared to males aged 45 
years or older, males of age 25 to 34 years were 44% 
(AOR=0.56; 95% CI [0.39, 0.81]) less likely to have 
raised cholesterol levels.  While males with BMI <18.5 
were less likely (AOR=0.13; 95% CI [0.03, 0.60]) to have 
raised cholesterol, males with BMI between 25.0 and 
29.9 were 2.49 (95% CI [1.29, 4.79]) times more likely to 
have raised cholesterol compared to males with BMI of 
30 or more.  Compared to males with waist/hip ratio of 
more than 1, males with waist/hip ratio of 1 or less were 
53% (AOR=0.47; 95% CI [0.25, 0.88]) less likely to have 
raised cholesterol. 
Among females, only age and BMI were significantly 
associated with raised cholesterol.  Females aged 25-34 
years were 22% (AOR=0.78; 95% CI [0.63, 0.96]) less 
likely to have raised cholesterol compared to females 
aged 45 years or older.  Compared to females with BMI of 
30 or more, females with BMI of 18.5-24.9 were 33% 
(AOR=0.67; 95% CI [0.51, 0.89]) less likely to have 
raised cholesterol levels, while females with BMI of 25.0-
29.9 were 57% (AOR=1.57; 95% CI [1.20, 2.06]) more 
likely to have raised cholesterol levels.
 Total Male Female
Factor
 
n (%) n (%) n (%)
Age group (years)
  
   
25-34
 
1015 (53.2) 337 (53.7) 675 (52.9)
   
35-44
 
413 (21.6) 135 (21.5) 277 (21.7)
   
45+
 
481 (25.2) 156 (24.8) 323 (25.3)
Sex
  
Male 634 (33.0) - -
Female 1288 (67.0) - -
Education
None 408 (21.5) 76 (12.2) 330 (26.0)
Primary 276 (14.5) 61 (9.8) 214 (16.9)
Secondary 679 (35.8) 242 (38.8) 435 (34.3)
College/university 534 (28.1) 244 (39.2) 290 (22.9)
 Total Males Females
Factor
 








1574 (84.2) 533 (87.2) 1036 (82.7)
Raised (5.2+) 296 (15.8) 78 (12.8) 217 (17.3)
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DISCUSSIONS
Perhaps the novel finding in the current study is that 
participants who were overweight were more likely to 
have raised cholesterol levels than obese participants. In 
addition, the current study presents the first estimate of 
prevalence of raised cholesterol in Zambia, and adds to a 
few reported levels of raised cholesterol levels in sub-
Saharan Africa.  Overall, 15.8% of the participants 
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Yes 0.79 (0.47, 1.34) - 0.60 (0.33, 1.09) -
No 1 1
Table 3: Factors associated with raised cholesterol levels in bivariate and multivariate logistic regression analyses stratified by 
sex in Lusaka, Zambia
(12.8% of males and 17.3% of females) had higher 
cholesterol levels in a community-based study in Lusaka-
Zambia. This prevalence is lower than the 21% reported in 
19Kenya  but higher than the 11% for females and 6% for 
20males in Malawi . 
The finding that overweight participants were more likely 
to have raised cholesterol levels than obese participants is 
interesting.  An explanation may be that when one is 
Medical Journal of Zambia, Vol. 39, No. 4 (2012)
15
obese, he/she may likely change habits and more likely to 
access healthcare services more readily than the not so fat.  
If cholesterol lowering drugs are to be prescribed, the 
doctor is more inclined to do so among the very heavy 
than they would to those not so heavy.  However, the 
current study did not obtain information on participants 
who were on drugs to lower cholesterol levels in order to 
substantiate our hypothesis.
Findings from this study indicate a sex difference in 
higher cholesterol values. This is similar to what 
21Njelekela et al.  reported from a study of cardiovascular 
disease risk factors in urban Tanzania, but different from 
22 23previous report from Nigeria  and South Africa  where 
there was no sex difference among Lagos and Soweto 
residents. The sex difference may be due to the fact that 
men living in Lusaka were more physically active than 
women. In a study of rural-urban gradient in the 
prevalence of the metabolic syndrome in Benin, Ntandou 
24et al.  reported that men who lived in city were as 
physically active as those living in semi-urban and rural 
areas while urban resident women were significantly less 
active than those from semi-urban and rural areas.
Among both males and females, age was positively 
associated with cholesterol levels. This is likely to be a 
consequence of diet, exercise or physical activity and 
lipid metabolism varying with age.   In males, the waist-
hip ratio of <1 was associated will reduced likelihood 
among males but not in females. The differences between 
males and females could be due to genetics and hormonal 
influences. No other variables assessed (alcohol, 
education) were associated with high cholesterol levels.
Limitations
The current study has several limitations. Socio-
demographic characteristics such as age, educational 
level, alcohol intake and diet were self-reported. To the 
extent that study respondents mis-reported, our results 
may be biased. However, there is no reason to suggest that 
individuals who were later found to have higher 
cholesterol levels were more likely to have mis-reported 
compared to those with lower values. Secondly, study 
respondents submitted blood samples for cholesterol 
assessment only once. There is likely to be intra-
individual variations in cholesterol level which was not 
considered in this study. While the consumption of fruits 
as a surrogate measure of healthy eating was assessed, a 
meta-analysis has shown that the consumption of nuts of 
nearly any type improves blood lipid levels, lowering 
total- and low-density lipoprotein (LDL)-cholesterol 
25levels, and improves important lipid ratios . 
Consumption of nuts was not assessed in the present 
study.
CONCLUSION 
The prevalence of high cholesterol was high among 
Lusaka residents, particularly among women. A series of 
surveys to determine changes in total and LDL 
cholesterol are needed to estimate changes in the health 
level of the residents in Lusaka.  These data could be used 
in the formulation of an action plan to prevent and control 
high cholesterol and its consequences among Zambian 
urban residents.  
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